Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

Thierry André(Inserm), Luis A. Díaz(Memorial Sloan Kettering Cancer Center)

New England Journal of Medicine

December 2, 2020

10.1056/nejmoa2017699

Cited by 2,898

Related Papers

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

|New England Journal of Medicine|2015|9.4k

Cancer Genome Landscapes

|Science|2013|8k

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

|Science|2017|6.6k

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

|The Lancet Oncology|2017|2.8k

Detection and localization of surgically resectable cancers with a multi-analyte blood test

|Science|2018|2.8k